Product Information
DOXYCYCLINE HYC DR 100 MG TAB is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $2.1836 per EA under NDC 23155014201. Its NADAC has been published 324 times since Aug 20, 2014.
FDA first approved this application on Apr 30, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the doxycycline hyclate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155014201
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINE HYCLATEApproval Type
Generic (ANDA)
FDA Application
ANDA200856FDA Approved
4/30/2013
TE Code
AB
On Market Since
4/30/2013
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE HYC DR 100 MG TAB has been published 324 times since Aug 20, 2014, and over the history we have for it it has declined 77.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1836 per EA |
|---|---|
| All-time high | $9.5303 (Feb 11, 2015) |
| All-time low | $1.6502 (Sep 18, 2024) |
| 52-week high | $2.3668 |
| 52-week low | $1.7822 |
| Median price | $5.3700 |
| Average price | $5.6864 |
| Largest weekly change | -58.0% (Apr 17, 2024) |
| Weeks tracked | 324 |
| Tracking since | Aug 20, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doxycycline hyclate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
doxycycline hyclate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE HYC DR 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE HYC DR 100 MG TAB, manufactured by Heritage Pharmaceuticals Inc., is $2.1836 per EA (NDC 23155014201), effective Sep 30, 2026.
How has the price of DOXYCYCLINE HYC DR 100 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE HYC DR 100 MG TAB has declined 77.1%. It has been tracked across 324 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE HYC DR 100 MG TAB?
Since Aug 20, 2014, the NADAC for DOXYCYCLINE HYC DR 100 MG TAB has ranged from a low of $1.6502 (Sep 18, 2024) to a high of $9.5303 (Feb 11, 2015), with a median of $5.3700 per EA.
Are there cheaper alternatives to DOXYCYCLINE HYC DR 100 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DOXYCYCLINE HYC DR 100 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXYCYCLINE HYC DR 100 MG TAB?
DOXYCYCLINE HYC DR 100 MG TAB (NDC 23155014201) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.